Jagsonpal Pharma's Stock Soars to New High, Outperforms Sector and Sensex
Jagsonpal Pharmaceuticals Ltd., a smallcap company in the pharmaceuticals and drugs industry, saw a 7.25% increase in its stock price on October 31st, 2024, reaching a new 52-week and all-time high of Rs. 550. This performance has been deemed as 'Hold' by MarketsMojo. The company has outperformed the sector and Sensex in the last month, showcasing its strong presence and potential in the market.
Jagsonpal Pharmaceuticals ., a smallcap company in the pharmaceuticals and drugs industry, has seen a significant increase in its stock price on October 31st, 2024. The stock gained 7.25%, closing at Rs. 550, which is also its new 52-week and all-time high. This performance has been deemed as 'Hold' by MarketsMOJO.
The stock has been on a consecutive gain for the last two days, with a total increase of 16.91% during this period. It opened with a gain of 2.34% today and touched an intraday high of Rs. 550, outperforming the sector by 2.35%. Jagsonpal Pharma is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In comparison to the Sensex, Jagsonpal Pharmaceuticals Ltd. has outperformed with a 1-day performance of 6.71% while the Sensex has seen a -0.72% performance. In the last month, Jagsonpal Pharmaceuticals Ltd. has shown a 29.27% increase, while the Sensex has seen a -5.82% performance.
This positive performance of Jagsonpal Pharmaceuticals Ltd. can be attributed to its strong presence in the pharmaceuticals and drugs industry. As a smallcap company, it has shown promising growth and potential in the market. Investors and experts are keeping a close eye on the company's performance, as it continues to make strides in the industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
